SCHEMBL25028300

SCHEMBL25028300

CCN(C)CCc1c[nH]c2c(C)c(F)cc(O)c12

nearest known ligand 0.53

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ HTR1A P08908 5/20 0.53
▸ HTR2A P28223 9/20 0.46
▸ HTR2C P28335 5/20 0.40
▸ HTR2B P41595 5/20 0.40
▸ HTR1D P28221 3/20 0.37
▸ HTR1B P28222 2/20 0.37
▸ DRD1 P21728 1/20 0.37
▸ HTR1E P28566 1/20 0.37
▸ ADORA2A P29274 1/20 0.37
▸ ADORA2B P29275 1/20 0.37
▸ HTR7 P34969 1/20 0.37
▸ DRD3 P35462 1/20 0.37
▸ HTR5A P47898 1/20 0.37
▸ HTR6 P50406 1/20 0.37
▸ MPO P05164 1/20 0.33
▸ SLC6A2 P23975 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25029922 0.89 HTR1A (0.67) HTR1AHTR2AHTR2CHTR2BHTR1D
SCHEMBL31105616 0.81 HTR1A (0.45) HTR1AHTR2AHTR1DHTR6MPO
SCHEMBL25030358 0.80 HTR1D (0.41) HTR1AHTR2AHTR2CHTR2BHTR1D
SCHEMBL25029861 0.79 MPO (0.44) HTR1AHTR2AHTR6MPO
SCHEMBL25030193 0.78 HTR2A (0.49) HTR1AHTR2AHTR2CHTR1DHTR1B
SCHEMBL25029867 0.77 HTR1A (0.57) HTR1AHTR2AHTR2CHTR2BHTR1D
SCHEMBL25748340 0.76 HTR1A (0.56) HTR1AHTR2AHTR2CHTR2BHTR1D
SCHEMBL25907490 0.75 HTR1A (0.55) HTR1AHTR2AHTR2CHTR2BHTR1D
SCHEMBL24420538 0.75 HTR1A (0.69) HTR1AHTR2AHTR2CHTR2BHTR1D
SCHEMBL29206396 0.73 HTR2A (0.54) HTR1AHTR2AHTR2CHTR2BHTR1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118055766-A Magic and non-magic serotonin receptor agonist and its preparing process and usage 库莱恩有限责任公司 2024-05-17 — — CN disclosed
US-11780807-B2 Benzoselenophene, benzothiophene, and benzofuran analogs and methods of modulating the serotonin 5-HT2C receptor Kuleon, LLC (US) 2023-10-10 — — US disclosed
US-11780807-B2 Benzoselenophene, benzothiophene, and benzofuran analogs and methods of modulating the serotonin 5-HT2C receptor Kuleon, LLC (US) 2023-10-10 — — US disclosed
US-20230257346-A1 BENZOSELENOPHENE AND SELENOPHENOPYRIDINE ANALOGS AND METHODS OF MODULATING THE SEROTONIN 5-HT2C RECEPTOR Kuleon, LLC (US) 2023-08-17 — — US disclosed
US-20230257346-A1 BENZOSELENOPHENE AND SELENOPHENOPYRIDINE ANALOGS AND METHODS OF MODULATING THE SEROTONIN 5-HT2C RECEPTOR Kuleon, LLC (US) 2023-08-17 — — US disclosed
WO-2023018864-A1 HALLUCINOGENIC AND NON-HALLUCINOGENIC SEROTONIN RECEPTOR AGONISTS AND METHODS OF MAKING AND USING THE SAME PSILOSTERICS, LLC (US) 2023-02-16 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11780807-B2 Benzoselenophene, benzothiophene, and benzofuran analogs and methods of modulating the serotonin 5-HT2C receptor HTR2C, HTR2A, HTR3C HTR1A 8/4885HTR2A 2/4885HTR2C 1/4885
US-20230257346-A1 BENZOSELENOPHENE AND SELENOPHENOPYRIDINE ANALOGS AND METHODS OF MODULATING THE SEROTONIN 5-HT2C RECEPTOR HTR2C, HTR2A, HTR3B HTR1A 9/4885HTR2A 2/4885HTR2C 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback